ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 1000

$914K Total Retail Price of All Prescriptions

Rank: 70 out of 1000

489 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 13,788 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 627 531 1 2
AMLODIPINE BESYLATE 548 518 2 6
HYDROCODONE-ACETAMINOPHEN 482 313 S3 3 1
LISINOPRIL 412 316 4 5
LEVOTHYROXINE SODIUM 396 292 5 4
SIMVASTATIN 389 291 6 3
FUROSEMIDE 385 328 7 7
PRAVASTATIN SODIUM 364 312 8 12
MELOXICAM 355 290 9 14
TRAMADOL HCL 340 248 10 13
POTASSIUM CHLORIDE 323 280 11 10
METOPROLOL SUCCINATE 305 271 12 21
ATORVASTATIN CALCIUM 253 236 13 18
METOPROLOL TARTRATE 245 190 14 19
DONEPEZIL HCL 237 235 15 32
METFORMIN HCL ER 202 136 16 44
NEXIUM 197 123 17 23
LOSARTAN POTASSIUM 184 162 18 25
ENALAPRIL MALEATE 173 144 19 58
CIPROFLOXACIN HCL 171 126 20 46
METFORMIN HCL 170 131 21 8
GABAPENTIN 167 131 22 11
GLIMEPIRIDE 165 145 23 34
CLOPIDOGREL 162 138 24 35
DIGOXIN 160 144 25 52
ZOLPIDEM TARTRATE 157 105 26 16
BENAZEPRIL HCL 157 133 26 61
ATENOLOL 156 133 28 24
TAMSULOSIN HCL 154 126 29 33
WARFARIN SODIUM 153 130 30 22
TRAZODONE HCL 151 132 31 29
BUMETANIDE 149 130 32 112
HYDROCHLOROTHIAZIDE 146 127 33 9
LANTUS 141 117 34 68
SERTRALINE HCL 140 78 35 26
LEVOFLOXACIN 129 104 36 73
CRESTOR 127 101 37 30
FLUOXETINE HCL 122 95 38 51
ROPINIROLE HCL 121 115 39 82
ISOSORBIDE MONONITRATE ER 115 108 40 71
ESTRADIOL 114 80 R 41 114
QUINAPRIL HCL 112 100 42 117
GENERLAC 112 101 42 231
VERAPAMIL ER 112 81 42 86
NAMENDA 108 108 45 43
CARVEDILOL 107 106 46 15
RISPERIDONE 104 93 47 87
PLAVIX 103 91 48 49
FENTANYL 102 76 S2 49 100
CYMBALTA 95 78 50 53
ALLOPURINOL 92 86 51 31
AMLODIPINE BESYLATE-BENAZEPRIL 90 90 52 59
RANITIDINE HCL 87 87 53 37
TRICOR 86 37 54 141
PAROXETINE HCL 84 67 55 63
CLONIDINE HCL 81 66 56 27
METHOCARBAMOL 80 61 R 57 79
PANTOPRAZOLE SODIUM 79 76 58 28
CYCLOBENZAPRINE HCL 74 26 R 59 39
PREMARIN 73 69 R 60 109
ACARBOSE 71 26 61 268
JANUVIA 71 54 61 85
RAMIPRIL 69 69 63 77
CITALOPRAM HBR 68 46 64 17
ALENDRONATE SODIUM 66 64 65 57
ESCITALOPRAM OXALATE 66 56 65 60
KLOR-CON 10 66 55 65 104
MECLIZINE HCL 65 47 68 80
PROPRANOLOL HCL 63 63 69 135
TRAMADOL HCL-ACETAMINOPHEN 63 54 69 151
SINGULAIR 62 58 71 84
METOCLOPRAMIDE HCL 62 53 71 99
AVODART 60 55 73 214
NIFEDIPINE ER 59 52 74 130
DIOVAN 59 58 74 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 43 76 70
BENZTROPINE MESYLATE 58 58 R 76 180
FENOFIBRATE 55 27 78 55
FLUTICASONE PROPIONATE 52 44 79 40
LOSARTAN-HYDROCHLOROTHIAZIDE 52 40 79 38
FAMOTIDINE 52 39 79 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 49 82 20
VENLAFAXINE HCL ER 51 23 82 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.